Karah Herdman Parschauer Evolus, Inc. (EOLS) insider trading activity

Karah Herdman Parschauer is Director of Evolus, Inc.. Currently has a direct ownership of 32,183 shares of EOLS, which is worth approximately $334,059. The most recent transaction as insider was on Mar 12, 2025, when has been sold 12,888 shares (Common Stock) at a price of $12.99 per share, resulting in proceeds of $167,415. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.2K

14.65% 3M change

14.65% 12M change

Total Value Held $334,059

Karah Herdman Parschauer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2025	SELL Open market or private sale	$167,415 $12.99 p/Share	12,888 Reduced 28.59%	32,183 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	7,364 Added 14.04%	45,071 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	6,464 Added 14.63%	37,707 Common Stock
Jan 30 2024	SELL Open market or private sale	$156,773 $13.14 p/Share	11,931 Reduced 27.63%	31,243 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	8,293 Added 16.11%	43,174 Common Stock
Jan 24 2022	BUY Grant, award, or other acquisition	-	15,568 Added 30.86%	34,881 Common Stock
Feb 05 2021	BUY Grant, award, or other acquisition	-	19,313 Added 50.0%	19,313 Common Stock

Also insider at

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

EVP and Chief Legal Officer

ARCT

Arcturus Therapeutics Holdings Inc. Healthcare

Director

TNYA

Tenaya Therapeutics, Inc. Healthcare

ANEB

Anebulo Pharmaceuticals, Inc. Healthcare

Director

KHP